1,164 reports of this reaction
3.3% of all LITHIUM CARBONATE reports
#1 most reported adverse reaction
TOXICITY TO VARIOUS AGENTS is the #1 most commonly reported adverse reaction for LITHIUM CARBONATE, manufactured by ANI Pharmaceuticals, Inc.. There are 1,164 FDA adverse event reports linking LITHIUM CARBONATE to TOXICITY TO VARIOUS AGENTS. This represents approximately 3.3% of all 35,528 adverse event reports for this drug.
Patients taking LITHIUM CARBONATE who experience toxicity to various agents should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXICITY TO VARIOUS AGENTS is moderately reported among LITHIUM CARBONATE users, representing a notable but not dominant share of adverse events.
In addition to toxicity to various agents, the following adverse reactions have been reported for LITHIUM CARBONATE:
The following drugs have also been linked to toxicity to various agents in FDA adverse event reports:
TOXICITY TO VARIOUS AGENTS has been reported as an adverse event in 1,164 FDA reports for LITHIUM CARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXICITY TO VARIOUS AGENTS accounts for approximately 3.3% of all adverse event reports for LITHIUM CARBONATE, making it one of the most commonly reported side effect.
If you experience toxicity to various agents while taking LITHIUM CARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.